Connect with us

Life Sciences

Techcyte Announces a Strategic Collaboration with Mayo Clinic to Create New Diagnostic Tests

Techcyte announced a strategic collaboration with Mayo Clinic to create new AI algorithms and workflows on the Techcyte Clinical Pathology AI Platform….

Published

on

This article was originally published by AITHORITY
Techcyte Announces a Strategic Collaboration with Mayo Clinic to Create New Diagnostic Tests

Techcyte announced a strategic collaboration with Mayo Clinic to create new AI algorithms and workflows on the Techcyte Clinical Pathology AI Platform.

AiThority Interview : AiThority Interview with Alan Holland, CEO and Founder of Keelvar

“We’re honored and excited to be collaborating with Mayo Clinic”

Techcyte’s Clinical Pathology AI Platform imports digital images of liquid-based samples acquired through whole slide scanners. These images are analyzed by deep learning algorithms that identify and classify target objects. The resulting images are verified by medical technologists after which the results are exported to lab information systems.

Techcyte AI experts will collaborate with Mayo Clinic on developing diagnostic testing with increased accuracy and efficiency to positively impact the practice of lab medicine and the patients that depend on the results.

“Mayo Clinic’s model of integrated care gives us unique data and expertise that, when combined with Techcyte’s AI platform, will produce diagnostics that can potentially revolutionize how lab medicine is practiced. This collaboration is another step in the transformation of health care to a platform model that benefits patients,” stated William G. Morice II, M.D., Ph.D., CEO and President of Mayo Clinic Laboratories.

Read More InterviewAiThority Interview with Marc Bolitho, CEO of Recogni

“We’re honored and excited to be collaborating with Mayo Clinic,” said Ben Cahoon, CEO of Techcyte. “The comprehensive vision and plans for enhancing laboratory medicine and taking digital pathology to the world is remarkable.”

Mayo Clinic has a financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.

Techcyte was founded in 2013 in Orem, Utah and is a world leader in AI-based digital diagnostics for lab medicine. Techcyte’s Clinical Pathology AI Platform uses deep machine learning to perform automated analysis of whole slide microscopy images, revolutionizing digital diagnostics for human, animal, and environmental clinics and labs.

 Latest Interview Insights : AiThority Interview with Shaun McGirr, Field CDO at Dataiku

 [To share your insights with us, please write to sghosh@martechseries.com] 

The post Techcyte Announces a Strategic Collaboration with Mayo Clinic to Create New Diagnostic Tests appeared first on AiThority.

diagnostics


machine learning
medicine

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending